💉⚗️"Vaccines are technically challenging to manufacture." @ihieurope.bsky.social spotlights #Inno4vac's efforts in building digital tools (e.g. mathematical models, digital twins & open-source integrative platforms), to reduce #vaccine manufacturing time. 📃 www.ihi.europa.eu/news-events/...

🎉1,000+ views & counting!🎉 Curious about controlled human #Influenza virus infection models strain selection, immune assays, and their role in advancing #vaccine development? 📖Take a moment to read #Inno4vac workshop report➡️ doi.org/10.1111/irv.... #ViewsMilestone #CHIMs @ihieurope.bsky.social

How do we know vaccines work in real life?💉🌍MVPE-CC project partners across Africa and Europe collected real-world evidence on the effectiveness and safety of malaria vaccines, ensuring that data drives decisions and every dose makes a difference. 🎥 youtu.be/kC9KCqVthZc

📢 New vacancy (German required)! Wir stellen ein: Bilanzbuchhalter (m/w/d) 📍 Heidelberg | 🏠 Hybrid möglich Erfahrung in Finanzbuchhaltung, SAP, HGB/IFRS? Werde Teil unseres internationalen Non-Profit-Teams und unterstütze die globale Impfstoffentwicklung. 📩 Jetzt bewerben www.euvaccine.eu/careers

📊 Case-control studies across Africa are helping researchers understand how malaria vaccines work in real-world settings, This work, led through the MVPE-CC project, turns data into evidence and evidence into life-saving actions. 🌍 🎥 youtu.be/kC9KCqVthZc

Case-control studies across Africa bring together researchers, ministries of health, health workers & communities to gather real-world data. This teamwork helps refine how #malaria vaccines are rolled out, ensuring stronger protection for those who need it most.🌍 🎥 youtu.be/t-km8MqyQbI

🚨TRANSVAC Academy: Open call!🚨 Work in vaccine R&D? Join expert-led, hands-on training in Animal Welfare & In vivo Imaging. Why apply? 💡Leading instructors 🤝Network w/ experts 🌍 @cepi.net-funded scholarships for LMIC applicants 📅Apply now: transvac.org #TRANSVACAcademy

The rollout of RTS,S and R21 vaccines is a historic step against malaria 🌍💉but the work continues. Real-world data, including case-control studies, is essential to confirm safety, measure effectiveness, & optimise dosing for maximum impact. 🎥 Learn more about CC studies: youtu.be/kC9KCqVthZc

EVI-led #PrIMAVeRa_AMR project has published an article on BioProcess International on the use of monoclonal antibodies to tackle #AMR, & how PrIMAVeRa's open-access digital platform can support evidence-based public health decisions. 📃 www.bioprocessintl.com/monoclonal-a... @ihieurope.bsky.social

🩺Cases: people with the disease 💪Controls: similar people without it Researchers compare exposure to a certain factor, e.g. vaccination & assess protection in real-world settings. 🔍 Fast & powerful, these studies provide vital evidence to guide life-saving policies. 🎥 youtu.be/kC9KCqVthZc

Case-control studies help us understand how vaccines work at the individual level in the real world.🌍Insights from CC studies in Ghana, Kenya & Malawi are guiding immunisation programmes & informing public health policy. 💡Evidence in action, turning data into protection youtu.be/kC9KCqVthZc?...

We are delighted to announce the 2nd Generation #Malaria Vaccine Consortium, a new global partnership created to accelerate malaria vaccine development, co-led by @paediatrics.ox.ac.uk & IRSS/CRUN in Burkina Faso. ➡️ www.euvaccine.eu/post/global-... #MalariaVaccine #GlobalHealth #Vaccines

A new EVI-led systematic review shows that nearly 1 in 5 pregnant women are affected by placental #malaria, in endemic regions, rising to almost 1 in 4 when using more sensitive methods. This work reflects EVI’s 20+ year commitment to advancing vaccine R&D for PM. www.euvaccine.eu/post/placent...

EVI co-hosted a 2-day translational vaccinology workshop with @mrcunitgambia.bsky.social as part of #MMVC, to strengthen skills in vaccine R&D & clinical trials 💉🩺 EVI led sessions on development, clinical trials & practical research. Read more⬇️ www.euvaccine.eu/post/boostin...

Great to join the 3rd Annual Trials’ Day hosted by @mrcunitgambia.bsky.social, discussing challenges and innovation in clinical trial design & delivery. 👩🏽‍🔬👨🏽‍🔬🩺💉 EVI shared perspectives on strengthening partnerships with African research centres ⬇️ www.euvaccine.eu/post/advanci... #lshtmtrialsday

🚀 We’re Hiring! EVI is seeking a Project Management Assistant to support international projects in vaccine R&D and #AMR. 🎯Read full job description and apply ➡️ www.euvaccine.eu/careers Join our diverse, international non-profit team working to advance global health.

For 10 years, EVI’s fellowship programme has trained scientists from across Africa & beyond, building skills, leadership & lasting collaborations in #vaccine research 💉 Special thanks to @who.int-TDR & EDCTP @globalhealthedctp3.bsky.social Learn more ⬇️ www.euvaccine.eu/post/ten-yea...

🤝 The #PrIMAVeRa_AMR consortium welcomes its newest partner: the European Clinical Research Alliance on Infectious Diseases (@ecraid.bsky.social)! 🔗 Read more: www.primavera-amr.eu/post/ecraid-... #EUfunded @ihieurope.bsky.social @ecraid.bsky.social

Vaccines are a powerful, preventive tool to tackle #AMR. EVI is advancing 💉new Shigella & ETEC vaccines,💡data tools for policymakers & 🧬AI-driven diagnostics. Together, we can #StopSuperbugs. #WAAW2025 #ActNow www.euvaccine.eu/post/world-a...

EVI & partners shared results @astmh.bsky.social 2025 on the development of placental #malaria vaccines to protect mothers & babies in endemic regions. 🎯Towards equitable vaccine innovation & safer pregnancies 🌍. 🤝 Ehime Univ, KHRC Ghana & GRAS Burkina www.euvaccine.eu/post/evi-at-... #EndMalaria

EVI was delighted to join the World Vaccine Congress Europe 2025. Dr. Irina Meln shared how EVI bridges academia, industry & regulators through projects like #Inno4Vac.🌍💉🎯 Read more➡️ www.euvaccine.eu/post/evi-at-...

#PrIMAVeRa_AMR project holds 4th annual meeting: discussing modelling impacts of vaccines & mAbs on #AMR, and sustainability of project outputs. Read more: www.primavera-amr.eu/post/primave...

“When a woman becomes pregnant for the first time, she is particularly vulnerable to malaria.” - Dr Flavia D’Alessio, Head of Reasearch at EVI 🤰🏾🦟💉 The #EUfunded and EVI-led ADVANCE-VAC4PM project is developing a placental malaria vaccine to protect mothers & babies. 🎥 youtu.be/shMblC2F3f8

The path to a vaccine for placental #malaria is long, but momentum is growing. 💉2 candidates in EVI-led projects, coordinated global trials, & strong EU–Africa collaboration bring us closer to protecting mothers & babies. 🔗Read projects.research-and-innovation.ec.europa.eu/en/horizon-m... #EUfunded

🌍 On #OneHealthDay, we’re reminded that human, animal & environmental health are one. 💉 #Vaccines protect across species, preventing outbreaks, saving lives, and safeguarding our planet. Protecting one means protecting all. #VaccinesWork #OneHealth

“Vaccines don’t usually stop transmission, and that’s a big problem.” 💉👃🏽#NOSEVAC work on #NasalVaccines to stop the spread of #flu, #COVID19, S. pneumoniae & whooping cough is featured on Vaccines Today. Thanks to all partners driving this key research🙌 🔗 Read: www.vaccinestoday.eu/stories/how-...

#Polio eradication proves what global collaboration can achieve. 💉 Cases down 99% since 1988, with types 2 & 3 eradicated and type 1 limited to Pakistan & Afghanistan. A triumph of science & solidarity. 🌍 Together, we journey toward a world free from preventable diseases. #WorldPolioDay #EndPolio